These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22999109)

  • 1. Comments on the ESC guidelines on cardiovascular disease prevention (version 2012). A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
    Diaz-Buschmann I; Castro A; Galve E; Calero MJ; Dalmau R; Guzmán G; Cordero A; Fácila L; Quiles J; Arrarte V; Diaz-Buschmann I; Alonso Gómez ÁM; Cequier Á; Comín J; Fernández-Ortiz A; Pan M; Fernández Lozano FW; Fernández-Ortiz A; Sanmartín M; Ferreira I; Brotons C; López Sendón JL; Mazón P; Alonso J; Abeytua M; González Juanatey JR; de Pablo C; Worner F; Castro-Beiras A;
    Rev Esp Cardiol (Engl Ed); 2012 Oct; 65(10):869-73. PubMed ID: 22999109
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
    Anguita M; Comin J; Almenar L; Crespo M; Delgado J; Gonzalez-Costello J; Hernandez-Madrid A; Manito N; Perez de la Sota E; Segovia J; Segura C; Alonso-Gomez AM; Anguita M; Cequier A; Comin J; Diaz-Buschmann I; Fernandez-Lozano I; Fernandez-Ortiz A; Gomez de Diego JJ; Pan M; Worner F; Alonso-Pulpon L; Bover R; Castro A; Diaz-Molina B; Gomez-Bueno M; Gonzalez-Juanatey JR; Lage E; Lopez-Granados A; Lupon J; Martinez-Dolz L; Munoz R; Pascual D; Ridocci F; Roig E; Varela A; Vazquez de Prada JA
    Rev Esp Cardiol (Engl Ed); 2012 Oct; 65(10):874-8. PubMed ID: 22999110
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments on the ESC/ESH guidelines for the management of arterial hypertension 2013. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
    Grupo de Trabajo de la SEC sobre la guía de hipertensión arterial ESC/ESH 2013, revisores expertos de la guía de hipertensión arterial ESC/ESH 2013 y Comité de Guías de Práctica Clínica de la SEC
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):842-7. PubMed ID: 24773990
    [No Abstract]   [Full Text] [Related]  

  • 4. European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
    Perk J; De Backer G; Gohlke H; Graham I; Reiner Z; Verschuren WM; Albus C; Benlian P; Boysen G; Cifkova R; Deaton C; Ebrahim S; Fisher M; Germano G; Hobbs R; Hoes A; Karadeniz S; Mezzani A; Prescott E; Ryden L; Scherer M; Syvänne M; Op Reimer WJ; Vrints C; Wood D; Zamorano JL; Zannad F;
    Int J Behav Med; 2012 Dec; 19(4):403-88. PubMed ID: 23093473
    [No Abstract]   [Full Text] [Related]  

  • 5. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).
    Kristensen SD; Knuuti J; Saraste A; Anker S; Bøtker HE; De Hert S; Ford I; Gonzalez Juanatey JR; Gorenek B; Heyndrickx GR; Hoeft A; Huber K; Iung B; Kjeldsen KP; Longrois D; Luescher TF; Pierard L; Pocock S; Price S; Roffi M; Sirnes PA; Uva MS; Voudris V; Funck-Brentano C;
    Eur J Anaesthesiol; 2014 Oct; 31(10):517-73. PubMed ID: 25127426
    [No Abstract]   [Full Text] [Related]  

  • 6. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).
    ; Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney MT; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FD; Løchen ML; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WM; ; ; De Backer G; Roffi M; Aboyans V; Bachl N; Bueno H; Carerj S; Cho L; Cox J; De Sutter J; Egidi G; Fisher M; Fitzsimons D; Franco OH; Guenoun M; Jennings C; Jug B; Kirchhof P; Kotseva K; Lip GY; Mach F; Mancia G; Bermudo FM; Mezzani A; Niessner A; Ponikowski P; Rauch B; Rydén L; Stauder A; Turc G; Wiklund O; Windecker S; Zamorano JL
    Eur J Prev Cardiol; 2016 Jul; 23(11):NP1-NP96. PubMed ID: 27353126
    [No Abstract]   [Full Text] [Related]  

  • 7. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
    Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GYH; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM;
    Eur Heart J; 2016 Sep; 37(36):2768-2801. PubMed ID: 27567406
    [No Abstract]   [Full Text] [Related]  

  • 8. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology.
    Aktaa S; Gencer B; Arbelo E; Davos CH; Désormais I; Hollander M; Abreu A; Ambrosetti M; Bäck M; Carballo D; Crawford C; Deaton C; Dendale P; Eijsvogels TMH; Galbraith M; Piepoli MF; Salzwedel A; Smulders Y; Wilhelm M; Biondi-Zoccai G; Mach F; Visseren FLJ; Gale CP
    Eur J Prev Cardiol; 2022 May; 29(7):1060-1071. PubMed ID: 34687540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC).
    Visseren FLJ; Mach F; Smulders YM; Carballo D; Koskinas KC; Bäck M; Benetos A; Biffi A; Boavida JM; Capodanno D; Cosyns B; Crawford C; Davos CH; Desormais I; Angelantonio ED; Franco OH; Halvorsen S; Richard Hobbs FD; Hollander M; Jankowska EA; Michal M; Sacco S; Sattar N; Tokgozoglu L; Tonstad S; Tsioufis KP; van Dis I; van Gelder IC; Wanner C; Williams B;
    Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):429. PubMed ID: 35525570
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Semergen; 2015 Apr; 41(3):149-57. PubMed ID: 25450438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines.
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR; ;
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):913-9. PubMed ID: 25443815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comments on the ESC guidelines on the management of valvular heart disease (version 2012). A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
    ; ; ; Alonso Gómez ÁM; Gómez de Diego JJ; Barba J; Barón G; Borrás X; Evangelista A; Fernández González ÁL; García Orta R; Gómez Doblas JJ; Hernández Antolín R; Hernández García JM; Mahía P; Sáez de Ibarra JI; Bermejo J; Cuenca Castillo J; García Fernández MÁ; García Fuster R; López J; López Haldón JE; Tornos P; San Román A; Sitges M; Vilacosta I; Zamorano JL; Anguita M; Cequier Á; Comín J; Diaz-Buschmann I; Fernández Lozano I; Fernández-Ortiz A; Pan M; Wornerm F
    Rev Esp Cardiol (Engl Ed); 2013 Feb; 66(2):85-9. PubMed ID: 24775380
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.
    Pagidipati NJ; Navar AM; Mulder H; Sniderman AD; Peterson ED; Pencina MJ
    JAMA; 2017 Apr; 317(15):1563-1567. PubMed ID: 28418481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmarking progress in the implementation of the Fourth Joint Societies' Task Force Guidelines on the Prevention of Cardiovascular Disease in Clinical Practice.
    Morgan K; Burke H; McGee H
    Eur J Prev Cardiol; 2013 Feb; 20(1):54-60. PubMed ID: 22345672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Clin Investig Arterioscler; 2015; 27(1):36-44. PubMed ID: 25444651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2014 European Society of Cardiology/European Society of Anaesthesiology guidelines on non-cardiac surgery: cardiovascular assessment and management: A short explanatory statement from the European Society of Anaesthesiology members who participated in the European Task Force.
    Longrois D; Hoeft A; De Hert S
    Eur J Anaesthesiol; 2014 Oct; 31(10):513-6. PubMed ID: 26656566
    [No Abstract]   [Full Text] [Related]  

  • 17. The ESC Global Affairs Committee (2018-20): tackling cardiovascular disease worldwide.
    Grobbee DE
    Cardiovasc Res; 2020 Dec; 116(14):e212-e214. PubMed ID: 33245755
    [No Abstract]   [Full Text] [Related]  

  • 18. ESC Committee for Practice Guidelines: providing knowledge to everyday clinical practice.
    Windecker S
    Cardiovasc Res; 2020 Sep; 116(11):e146-e148. PubMed ID: 32845966
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.
    Delabays B; de La Harpe R; Vollenweider P; Fournier S; Müller O; Strambo D; Graham I; Visseren FLJ; Nanchen D; Marques-Vidal P; Vaucher J
    Eur J Prev Cardiol; 2023 Nov; 30(17):1856-1864. PubMed ID: 37290056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman M; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; ;
    Atherosclerosis; 2011 Jul; 217(1):3-46. PubMed ID: 21882396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.